AAAAAA
Results:
1-11
|
Results: 11
Authors:
BERGAN S
RUGSTAD HE
KLEMETSDAL B
GIVERHAUG T
BENTDAL O
SODAL G
HARTMANN A
AARBAKKE J
STOKKE O
Citation: S. Bergan et al., POSSIBILITIES FOR THERAPEUTIC DRUG-MONITORING OF AZATHIOPRINE - 6-THIOGUANINE NUCLEOTIDE CONCENTRATIONS AND THIOPURINE METHYLTRANSFERASE ACTIVITY IN RED-BLOOD-CELLS, Therapeutic drug monitoring, 19(3), 1997, pp. 318-326
Authors:
OTTERNESS D
SZUMLANSKI C
LENNARD L
KLEMETSDAL B
AARBAKKE J
PARKHAH JO
IVEN H
SCHMIEGELOW K
BRANUM E
OBRIEN J
WEINSHILBOUM R
Citation: D. Otterness et al., HUMAN THIOPURINE METHYLTRANSFERASE PHARMACOGENETICS - GENE SEQUENCE POLYMORPHISMS, Clinical pharmacology and therapeutics, 62(1), 1997, pp. 60-73
Authors:
OTTERNESS D
SZUMLANSKI C
WOOD T
LENNARD L
KLEMETSDAL B
AARBAKKE J
PARKHAH J
IVEN H
BRANUM E
OBRIEN J
WEINSHILBOUM R
Citation: D. Otterness et al., THIOPURINE METHYLTRANSFERASE (TPMT) PHARMACOGENETICS - POLYMORPHISM CHARACTERIZATION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 4-4
Authors:
BERGAN S
RUGSTAD HE
BENTDAL O
HARTMANN A
KLEMETSDAL B
AARBAKKE J
STOKKE O
Citation: S. Bergan et al., MONITORING AZATHIOPRINE THERAPY BY MEASURING ACTIVE METABOLITES IN RENAL-ALLOGRAFT RECIPIENTS, Kidney international, 49(3), 1996, pp. 931-931
Authors:
GIVERHAUG T
KLEMETSDAL B
LYSAA R
AARBAKKE J
Citation: T. Giverhaug et al., INTRAINDIVIDUAL VARIABILITY IN RED-BLOOD-CELL THIOPURINE METHYLTRANSFERASE ACTIVITY, European Journal of Clinical Pharmacology, 50(3), 1996, pp. 217-220
Authors:
PARKHAH JO
KLEMETSDAL B
LYSAA R
CHOI KH
AARBAKKE J
Citation: Jo. Parkhah et al., THIOPURINE METHYLTRANSFERASE ACTIVITY IN A KOREAN POPULATION-SAMPLE OF CHILDREN, Clinical pharmacology and therapeutics, 60(1), 1996, pp. 68-74
Authors:
KLEMETSDAL B
FLAEGSTAD F
AARBAKKE J
Citation: B. Klemetsdal et al., THERE A GENDER DIFFERENCE IN RED-BLOOD-CELL THIOPURINE METHYLTRANSFERASE ACTIVITY IN HEALTHY-CHILDREN, Medical and pediatric oncology, 25(6), 1995, pp. 445-449
Authors:
BERGAN S
RUGSTAD HE
BENTDAL O
SODAL G
HARTMANN A
KLEMETSDAL B
AARBAKKE J
STOKKE O
Citation: S. Bergan et al., OPTIMIZATION OF AZATHIOPRINE THERAPY BY MEASURING 6-THIOGUANINE NUCLEOTIDES AND METHYLATED MERCAPTOPURINE IN RENAL-ALLOGRAFT RECIPIENTS, Transplantation proceedings, 27(6), 1995, pp. 3426-3426
Authors:
KLEMETSDAL B
STRAUME B
LYSAA R
GIVERHAUG T
AARBAKKE J
Citation: B. Klemetsdal et al., ERYTHROCYTE FRACTION AFFECTS RED-BLOOD-CELL THIOPURINE METHYLTRANSFERASE ACTIVITY, European Journal of Clinical Pharmacology, 48(6), 1995, pp. 495-499
Authors:
KLEMETSDAL B
STRAUME B
GIVERHAUG T
AARBAKKE J
Citation: B. Klemetsdal et al., LOW CATECHOL-O-METHYLTRANSFERASE ACTIVITY IN A SAAMI POPULATION, European Journal of Clinical Pharmacology, 46(3), 1994, pp. 231-235
Authors:
KLEMETSDAL B
WIST E
AARBAKKE J
Citation: B. Klemetsdal et al., GENDER DIFFERENCE IN RED-BLOOD-CELL THIOPURINE METHYLTRANSFERASE ACTIVITY, Scandinavian journal of clinical & laboratory investigation, 53(7), 1993, pp. 747-749
Risultati:
1-11
|